EXPLORER scanner cuts total-body PET imaging time for cancer detection to 20 minutes
Uses a variation of the Patlak plot — called the relative Patlak plot — to generate high-quality parametric images
OEMs dominate PET/CT service landscape, IMV reports
Among midsized hospitals, OEM support stood at 77%, with 20% in-house and 13% ISO
IBA debuts compact synthesizer for radiopharmaceutical manufacturing
CASSY is designed to integrate into existing lab workflows and optimize space within hot cells
Ratio Therapeutics plans radiopharmaceutical manufacturing site in Salt Lake City
Designed for end-to-end production of radiopharmaceuticals, with an eye toward scaling up for commercial supply
SHINE Technologies to acquire Lantheus’ SPECT division
Deal includes the manufacturing operations at Lantheus’ North Billerica, Massachusetts site
Blue Earth Therapeutics begins phase 2 trial of lutetium-based radioligand for prostate cancer
Assessing efficacy and safety across different dosing regimens
SpectronRx passes FDA inspection with no observations for Indianapolis facility
Plans to expand operations to meet global demand for radiopharmaceuticals
SHINE enters UAE market with Modawina partnership for Lu-177 distribution
Extends presence across the Europe, Middle East, and Africa regions
PET procedure volumes in US rose 12% in 2024
Demand grew alongside limited expansion in installed imaging capacity, according to IMV
SHINE and Sumitomo form partnership to expand radioisotope supply in Asia
The agreement will focus on establishing supply chains for SHINE’s core offerings
FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
Approved for patients who received one androgen receptor pathway inhibitor (ARPI) but not chemotherapy